Progress and challenges in the vaccine-based treatment of head and neck cancers.
about
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse modelshrHPV E5 oncoprotein: immune evasion and related immunotherapies.Immunotherapy in new pre-clinical models of HPV-associated oral cancers.Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.Immunologic treatments for precancerous lesions and uterine cervical cancer.Activities of stromal and immune cells in HPV-related cancers.
P2860
Progress and challenges in the vaccine-based treatment of head and neck cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@en
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@nl
type
label
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@en
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@nl
prefLabel
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@en
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@nl
P2860
P356
P1476
Progress and challenges in the vaccine-based treatment of head and neck cancers.
@en
P2093
Aldo Venuti
P2860
P2888
P356
10.1186/1756-9966-28-69
P5008
P577
2009-05-27T00:00:00Z
P5875
P6179
1035465419